CHEST 2019

Complete Coverage

COPD

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

CHEST 2019

Influenza Vaccinations Benefit Patients Hospitalized With Pneumonia

In-hospital influenza vaccination may lower costs and risk for readmission or death.

CHEST 2019 In-Depth Asthma

Oral Montelukast Not Effective as Adjuvant in Pediatric Acute Moderate Asthma

By

Florence Chaverneff, Ph.D.

Children with an acute exacerbation of asthma were randomly assigned to receive a single tablet of montelukast or placebo.

CHEST 2019 In-Depth Asthma

Despite Risks, Long-Term Oral Corticosteroid Use Still Common in Asthma

By

Pulmonology Advisor Contributing Writer

Despite the potential for adverse events, long-term use of oral corticosteroid medications is common among patients with poor asthma control.

CHEST 2019 In-Depth Asthma

Asthma Linked to Reduced Mortality in Adults Admitted for Myocardial Infarction

By

Britt Gambino

Asthma appeared to be associated with lower mortality in patients admitted to the hospital with myocardial infarction.

CHEST 2019 In-Depth Asthma

Dupilumab Reduced Severe Exacerbations in Oral Corticosteroid-Dependent Asthma

By

Lea Eslava-Kim, PharmD

Dupilumab significantly reduced severe asthma exacerbations in patients with oral corticosteroid-dependent severe asthma with and without early improvements in lung function.

CHEST 2019 In-Depth Asthma

Mepolizumab Effective in Asthma Regardless of Background Controller Therapies

By

Pulmonology Advisor Contributing Writer

Irrespective of the type and number of background controller therapies, mepolizumab consistently reduced the annual rate of exacerbations in severe eosinophilic asthma compared with placebo.

CHEST 2019 In-Depth Asthma

Long-Term Asthma Control in Children: ICS With and Without LABA

By

Pulmonology Advisor Contributing Writer

Better asthma control in children can be achieved by either increasing inhaled corticosteroid dose or by switching to a combination of inhaled corticosteroid plus long-acting beta agonist with similar treatment outcomes.

CHEST 2019 In-Depth COPD

How Do Seasonal Variants Affect Outcomes, Costs in COPD?

By

Madeline Morr

Researchers conducted a retrospective analysis to identify seasonal variations in outcomes for COPD exacerbation admissions and the effect on healthcare resource utilization.

CHEST 2019 In-Depth COPD

Aclidinium Bromide Safe, Reduces Exacerbations in COPD With CV Risk

By

Britt Gambino

Treatment with aclidinium bromide reduced the rate of exacerbations in patients with moderate to severe COPD and high cardiovascular risk.